Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.010
-0.050 (-1.63%)
At close: Feb 21, 2025, 4:00 PM
3.040
+0.030 (1.00%)
After-hours: Feb 21, 2025, 6:48 PM EST
Aquestive Therapeutics Employees
Aquestive Therapeutics had 135 employees as of December 31, 2023. The number of employees increased by 5 or 3.85% compared to the previous year.
Employees
135
Change (1Y)
5
Growth (1Y)
3.85%
Revenue / Employee
$436,296
Profits / Employee
-$260,689
Market Cap
274.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
AQST News
- 10 days ago - Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting - GlobeNewsWire
- 6 weeks ago - Aquestive Therapeutics: Five Foci For 2025 - Seeking Alpha
- 3 months ago - Undercovered Dozen: Asbury Automotive, Globalstar, Northland Power, Aquestive Therapeutics + - Seeking Alpha
- 3 months ago - Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Aquestive: Rare Opportunity With Dual Platform Strategy - Seeking Alpha
- 3 months ago - Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - GlobeNewsWire
- 5 months ago - Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th - GlobeNewsWire